Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

The effector loop and prenylation site of R-Ras are involved in the regulation of integrin function

Abstract

The closely related small GTP-binding proteins H-Ras and R-Ras have opposing effects on the regulation of integrin cell adhesion receptors. To gain insight into the properties of R-Ras with respect to the regulation of integrin function and interactions with downstream effectors we performed an analysis of R-Ras variants containing mutations in the effector binding domain and C-terminal prenylation site. We found that the activation of the downstream effector PI 3-kinase was sensitive to mutations in the effector binding domain, as was the binding to the effectors, Ral-GDS, Raf-1 and the novel effector Nore1. Furthermore, specific mutations in the effector binding loop and C-terminal prenylation motif impaired the ability of R-Ras to regulate integrin function in CHO cells. However, the ability of the R-Ras effector loop mutants to bind, and activate known effectors did not correlate with their ability to regulate integrin function. Thus, the known R-Ras effectors are not critical for regulating integrin activation, at least in CHO cells. Consequently, these studies provide insight into the structural basis of the interactions between R-Ras and its candidate effectors and suggest the existence of novel mechanisms through which this GTPase could regulate cell adhesion.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Baker EK, Tozer EC, Pfaff M, Shattil SJ, Loftus JC and Ginsberg MH. . 1997 Proc. Natl. Acad. Sci. USA 94: 1973–1978.

  • Bos JL. . 1997 Biochim. Biophys. Acta 1333: M19–M31.

  • Cox AD, Brtva TR, Lowe DG and Der CJ. . 1994 Oncogene 9: 3281–3288.

  • Gietz RD, Triggs-Raine B, Robbins A, Graham KC and Woods RA. . 1997 Mol. Cell Biochem. 172: 67–79.

  • Hofer F, Fields S, Schneider C and Martin GS. . 1994 Proc. Natl. Acad. Sci. USA 91: 11089–11093.

  • Huff SY, Quilliam LA, Cox AD and Der CJ. . 1997 Oncogene 14: 133–143.

  • Hughes PE, Renshaw MW, Pfaff M, Forsyth J, Keivens VM, Schwartz MA and Ginsberg MH. . 1997 Cell 88: 521–530.

  • Joneson T, White MA, Wigler MH and Bar-Sagi D. . 1996 Science 271: 810–812.

  • Keely PJ, Rusyn EV, Cox AD and Parise LV. . 1999 J. Cell Biol. 145: 1077–1088.

  • Khosravi-Far R, Campbell S, Rossman KL and Der CJ. . 1998 Adv. Cancer Res. 72:: 57–107.

  • Khwaja A, Lehmann K, Marte BM and Downward J. . 1998 J. Biol. Chem. 273: 18793–18801.

  • Kikuchi A, Demo SD, Ye ZH, Chen YW and Williams LT. . 1994 Mol. Cell Biol. 14: 7483–7491.

  • Kinashi T, Katagiri K, Watanabe SI, Vanhaesebroeck B, Downward J and Takatsu KJ. . 2000 J. Biol. Chem. In press.

  • Lai CC, Boguski M, Breok D and Powers S. . 1993 Mol. Cell Biol. 13: 1345–1352.

  • Lowe DG, Capon DJ, Delwart E, Sakaguchi AY, Naylor SL and Goeddel DV. . 1987a Cell 48: 137–146.

  • Lowe DG and Goeddel DV. . 1987b Mol. Cell Biol. 7: 2845–2856.

  • Magee T and Marshall C. . 1999 Cell 98: 9–12.

  • Marte BM, Rodriguez-Viciana P, Wennstrom S, Warne PH and Downward J. . 1997 Curr. Biol. 7: 63–70.

  • Osada M, Tolkacheva T, Li W, Chan TO, Tsichlis PN, Saez R, Kimmelman AC and Chan AM. . 1999 Mol. Cell Biol. 19: 6333–6344.

  • O'Toole TE, Katagiri Y, Faull RJ, Peter K, Tamura R, Quaranta V, Loftus JC, Shattil SJ and Ginsberg MH. . 1994 J. Cell Biol. 124: 1047–1059.

  • Park SH and Weinberg RA. . 1995 Oncogene 11: 2349–2355.

  • Peterson SN, Trabalzini L, Brtva TR, Fischer T, Altschuler DL, Martelli P, Lapetina EG, Der CJ and White GC. . 1996 J. Biol. Chem. 271: 29903–29908.

  • Rey I, Taylor-Harris P, van Erp H and Hall A. . 1994 Oncogene 9: 685–692.

  • Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ, Waterfield MD and Downward J. . 1994 Nature 370: 527–532.

  • Rodriguez-Viciana P, Warne PH, Khwaja A, Marte BM, Pappin D, Das P, Waterfield MD, Ridley A and Downward J. . 1997 Cell 89: 457–467.

  • Seabra MC. . 1998 Cell Signal. 10: 167–172.

  • Sethi T, Ginsberg MH, Downward J and Hughes PE. . 1999 Mol. Biol. Cell 10: 1799–1809.

  • Shattil SJ, Hoxie JA, Cunningham M and Brass LF. . 1985 J. Biol. Chem. 260: 11107–11114.

  • Spaargaren M and Bischoff JR. . 1994 Proc. Natl. Acad. Sci. USA 91: 12609–12613.

  • Spaargaren M, Martin GA, McCormick F, Fernandez-Sarabia MJ and Bischoff JR. . 1994 Biochem. J. 300: 303–307.

  • Takayama S and Reed JC. . 1997 Methods Mol. Biol. 69:: 171–184.

  • Urano T, Emkey R and Feig LA. . 1996 EMBO J. 15: 810–816.

  • Vavvas D, Li X, Avruch J and Zhang XF. . 1998 J. Biol. Chem. 273: 5439–5442.

  • Wennstrom S and Downward J. . 1999 Mol. Cell Biol. 19: 4279–4288.

  • White MA, Nicolette C, Minden A, Polverino A, Van Aelst L, Karin M and Wigler MH. . 1995 Cell 80: 533–541.

  • Wolthuis RM, Bauer B, van't Veer LJ, de Vries-Smits AM, Cool RH, Spaargaren M, Wittinghofer A, Burgering BM and Bos JL. . 1996 Oncogene 13: 353–362.

  • Zhang Z, Vuori K, Wang H, Reed JC and Ruoslahti E. . 1996 Cell 85: 61–69.

  • Zou JX, Wang B, Kalo MS, Zisch AH, Pasquale EB and Ruoslahti E. . 1999 Proc. Natl. Acad. Sci. USA 24: 13813–13818.

Download references

Acknowledgements

B Oertli is supported by grants from the Swiss National Science Foundation and the Novartis Foundation (former Ciba-Geigy Jubilaeumstiftung). J Han is supported by a postdoctoral fellowship from the Arthritis Foundation. BM Marte was supported by a European Union Human Capital and Mobility Fellowhip and T Sethi by a Medical Research Council (UK) travelling fellowship. J Downward is supported by the Imperial Cancer Research Fund. MH Ginsberg is supported by grant # HL57900 from the National Institutes of Health. PE Hughes is the recipient of a senior fellowship from the Leukemia Society of America.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oertli, B., Han, J., Marte, B. et al. The effector loop and prenylation site of R-Ras are involved in the regulation of integrin function. Oncogene 19, 4961–4969 (2000). https://doi.org/10.1038/sj.onc.1203876

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203876

Keywords

This article is cited by

Search

Quick links